| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |